Ultra Low Dose Orbital Radiation Therapy in Treating Patients With Stage I-IV Indolent B-cell Lymphoma or Mantle Cell Lymphoma

Clinical trial NCT02494700 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT02494700
Sponsor: M.D. Anderson Cancer Center
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Ann Arbor Stage I B-Cell Non-Hodgkin Lymphoma Ann Arbor Stage I Grade 1 Follicular Lymphoma Ann Arbor Stage I Grade 2 Follicular Lymphoma Ann Arbor Stage I Indolent Adult Non-Hodgkin Lymphoma Ann Arbor Stage I Mantle Cell Lymphoma Ann Arbor Stage II B-Cell Non-Hodgkin Lymphoma Ann Arbor Stage II Grade 1 Follicular Lymphoma Ann Arbor Stage II Grade 2 Follicular Lymphoma Ann Arbor Stage II Indolent Adult Non-Hodgkin Lymphoma Ann Arbor Stage II Mantle Cell Lymphoma Ann Arbor Stage III B-Cell Non-Hodgkin Lymphoma Ann Arbor Stage III Grade 1 Follicular Lymphoma

Start date: 2015-07-06
Primary completion: 2027-06-30
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.